» Articles » PMID: 24206550

Colonoscopy Quality Assessment in a Mass Population Screening Programme Based on Faecal Occult Blood Test

Overview
Specialty Gastroenterology
Date 2013 Nov 12
PMID 24206550
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: the success of colorectal cancer (CRC) screening programmes largely depends on the quality of the events, processes and outcomes and therefore, quality assurance of endoscopy is an essential component. The quality indicators for colonoscopy in a screening programme setting are different from those performed in symptomatic people. The objective of this study was to report the main quality indicators of colonoscopies performed after a positive faecal occult blood test (FOBT) in a CRC screening programme in Catalonia.

Methods: the period of study includes three rounds of the CRC screening programme from June 2006 to July 2013. Two types of FOBT were used: a qualitative biochemical guaiac-based test (gFOBT) and a quantitative immunochemical test (FIT). Quality indicators analysed in this study were compared to recommended colonoscopy standards from the published guidelines.

Results: during the study period, 1,806 colonoscopies were performed in 1,691 individuals with a positive FOBT. All indicators were within the standard except waiting time to colonoscopy. Caecal intubation rate was 95.6 % and adequate bowel cleansing 93.6 %. Adenoma detection rate was better using FIT than gFOBT, 30.7 and 3.8 per 1,000 screenees, respectively. Cancer detection rate was also greater using FIT. Nearly 62 % of cancers were diagnosed at an early stage. The overall complication rate was 10.7 ‰.

Conclusion: although the majority of results reached the recommended standards, some areas have been identified for quality enhancement. Continuous monitoring of quality indicators is essential for improving the current effectiveness of CRC screening programmes.

Citing Articles

Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review.

Wang A, Lee B, Patel S, Whitaker E, Issaka R, Somsouk M J Med Screen. 2021; 28(4):379-388.

PMID: 33683155 PMC: 8423851. DOI: 10.1177/0969141321997482.


Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.

Li C, Tan F, Pei Q, Zhou Z, Zhou Y, Zhang L Cell Prolif. 2019; 52(4):e12632.

PMID: 31094023 PMC: 6668983. DOI: 10.1111/cpr.12632.


Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs.

Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R United European Gastroenterol J. 2017; 5(2):255-260.

PMID: 28344793 PMC: 5349366. DOI: 10.1177/2050640616660662.


Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Binefa G, Garcia M, Mila N, Fernandez E, Rodriguez-Moranta F, Gonzalo N Sci Rep. 2016; 6:19532.

PMID: 26787510 PMC: 4726304. DOI: 10.1038/srep19532.


Should Assessment of Quality Indicator of Colonoscopy Be Varied Depending on the Colonoscopic Technique Level?.

Choung B, Kim S, Yoo K, Seo S, Kim I, Lee S Dig Dis Sci. 2015; 61(3):731-6.

PMID: 26576553 DOI: 10.1007/s10620-015-3954-8.